Concepedia

Hayley Binch

HB

8

Publications

319

Citations

8

H-Index

1995

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Hayley Binch is an author at Vertex Pharmaceuticals (United States) specializing in biochemistry, natural sciences, and drug discovery.

Top concepts

Publications per year

1995–2014

8

Publications

8

The discovery of the potent aurora inhibitor MK-0457 (VX-680)

David Bebbington, Hayley Binch, Jean‐Damien Charrier et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 99 citations · Full text

, , +8

CH···O and CH···N Hydrogen Bonds in Ligand Design:  A Novel Quinazolin-4-ylthiazol-2-ylamine Protein Kinase Inhibitor

Albert C. Pierce, Ernst ter Haar, Hayley Binch et al. · Journal of Medicinal Chemistry · 2005 · 79 citations · Full text

, , +17

Chemical synthesis of GDP-l-galactose and analogues

Hayley Binch, Katja Stangier, Joachim Thiem · Carbohydrate Research · 1998 · 49 citations

, , +5

Reductive cleavage as a route to carbohydrate enolates. Applications to the synthesis of C-linked disaccharides

Hayley Binch, Andrew M. Griffin, Sabine Schwidetzky et al. · Journal of the Chemical Society Chemical Communications · 1995 · 24 citations

, , +14

Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists

Pramod V. Joshi, Corey L. Anderson, Hayley Binch et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 24 citations · Full text

, , +8

Rows per page

1–5 of 8